Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Opus Genetics, Inc.RNN · Entity 5892 | Director | June 06, 2019 | June 07, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Opus Genetics, Inc.
Report date June 06, 2019 · Filed June 07, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.23 · Expires 2029-06-06 | Direct | 3,537 |
Reported balance
After 2019-06-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-06 · Grant · Acquired 3,537 · Balance 3,537 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2019 Filed Jun 7, 2019 20:21 UTC | Opus Genetics, Inc. RNN · Entity 5892 | GrantStock Option (right to buy) · Derivative | 3,537 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001140361-19-010678 · form4.xml · derivative · entry 1 Cheong Kwang Soo · CIK 0001361686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,537 Underlying: Common Stock · 3,537 shares Expires 2029-06-06 Read SEC document |
| June 28, 2018 Filed Jun 29, 2018 20:33 UTC | Opus Genetics, Inc. RNN · Entity 5892 | GrantStock Option (right to buy) · Derivative | 39,742 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0001140361-18-030725 · form4.xml · derivative · entry 1 Cheong Kwang Soo · CIK 0001361686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,742 Underlying: Common Stock · 39,742 shares Expires 2028-06-28 Read SEC document |
| April 11, 2017 Filed Apr 12, 2017 21:26 UTC | Opus Genetics, Inc. RNN · Entity 5892 | GrantStock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001140361-17-015714 · form4.xml · derivative · entry 1 Cheong Kwang Soo · CIK 0001361686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-04-11 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.